J9213 Interferon alfa-2a injection
Also known as: interferon alfa-2a, Roferon-A
Intravenous injection of interferon alfa-2a, a recombinant human interferon with antiviral and immunomodulatory properties.
In Plain Language
immune-boosting cancer drug; antiviral therapy
Clinical Context
Used for hairy cell leukemia, chronic myeloid leukemia, and certain solid tumors.
RVU Information
CPT J9213 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9213?
CPT J9213 (Interferon alfa-2a injection) is a J Codes (Drugs) code. Intravenous injection of interferon alfa-2a, a recombinant human interferon with antiviral and immunomodulatory properties.
How is J9213 administered?
CPT J9213 is administered by a healthcare provider, typically via injection or infusion. Used for hairy cell leukemia, chronic myeloid leukemia, and certain solid tumors. It is used by Hematology/Oncology, Medical Oncology.
When is CPT J9213 used?
Used for hairy cell leukemia, chronic myeloid leukemia, and certain solid tumors.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.